Аутовоспалительные заболевания-современный взгляд на проблему
https://doi.org/10.14412/1995-4484-2009-144
Аннотация
Аутовоспалительными заболеваниями (синдромами) человека (Human autoinflammatory disease - HIDS) называют гетерогенную группу редких, генетически детерминированных состояний, характеризующихся непровоцируемыми приступами воспаления и проявляющихся лихорадкой и клинической симптоматикой, напоминающей ревматическую, при отсутствии аутоиммунных или инфекционных причин [1]. Аутовоспалительные синдромы дебютируют чаще всего в детском возрасте, иногда на первом году жизни, и поэтому являются в первую очередь педиатрической проблемой. Большинство заболеваний из указанной группы относятся к редкой патологии. Однако это во многом обусловлено трудностью диагностики и плохим знанием указанных заболеваний педиатрами во всём мире. Между тем как реальный шанс встретить пациента с подобной патологией есть у каждого практикующего педиатра, в том числе в России.
Список литературы
1. <div><p>Fietta P. Autoinflammatory disease: the hereditary periodic fever syndromes Acta Biol. Ateneo Parmense, 2004, 75, 92-9.</p><p>Reimann H.A. Periodic disease A probable syndrome including periodic fever, benign paroxysmal peritonitis, cyclic neutropenia and intermittent arthralgia. JAMA, 1948, 136, 239-44.</p><p>Galeazzi M., Gasbarrini G., Ghirandello A. et al. Autoinflamatory syndromes. Clin. Exp. Rheumatol., 2006, 24(suppl.40), 79-85.</p><p>Galon J., Aksentijevich I., Mc Dermott F., et al. TNFRSF1A mutations and autoinflammatory syn- dromes. Curr.Opin. Immunol., 2000, 12, 479-86.</p><p>Drenth G., van der Meer G.W. Hereditary Periodic fever. New England J.Med., 2001, 345, 24, 1748-57.</p><p>Виноградова О.М. Периодическая болезнь М., Медицина, 1973</p><p>Kuijk L.M., Hoffman H.L., Neven B., Frenkel J. Episodic autoinflammatory disorders in children. In Handbook of Systemic Autoimmune Disease, v.6 Pediatrcs in Systemic Autoimmune Disease. Ed. R.Cimas, Lehman T. Elselvier, 2008, 119-35.</p><p>The French FMF Consortium. A candidate gene for familial Mediterrnean fever. Nat. Genet., 1997, 17, 25-31.</p><p>The International FMF Consortium. Ancient missense mutation in a new member of the RoRet gene family are likely to cause familial Mediterrnean fever. Cell, 1997, 90,797-807.</p><p>Aldea A., Campistol J.M., Arostegui J.I. et al. A severe autosomal-dominant periodic inflammatory disorder with renal AA-amyloidosis to the MEFV H478Y variant in a Spanish kindred: an unusual familial Mediterrnean fever phenotype or another MEFV-associated periodic inflammatory disorder? Am.J. Med. Genet., 2004, 124, A67-73.</p><p>Gazeneuve C., Ajrapetyan H., Papin S et al. Identification of MEFV-independent modyfing genetic factors for familial Mediterrnean fever. Am.J. Med. Genet., 2000, 67,1136-43.</p><p>Stojanov S., Kastner D.L. Familial autoinflammatory disease: genetics, pathogenesis and treatment. Curr. Opin. Rheumatol., 2005, 17, 586-99.</p><p>Aypar E., Ozen S., Okur H., et al. Th1 polarization in familial Mediterrnean fever. J.Rheumatol., 2003, 30, 2011-3.</p><p>Notamicola C, Didelot M.N., Seguret F. et al. Enchanced cytokine mRNA levels in attack-free patients with familial Mediterrnean fever. Genes Immun., 2002, 3, 43-5.</p><p>Kiraz S., Ertenli I., Ozturk M.A. et al. Increased soluble FAS suggests delayed apoptosis in familial Mediterranean fever complicated with amyloidosis. J.Rheumatol., 2003, 30, 313-5.</p><p>Grateau G. Clinical and genetic aspects of the hereditary periodic fever syndromes. Rheumatol., 2004, 43, 410-5.</p><p>Ozen S. Familial mediterranean fever: revisiting an ancient disease. Eur. J. Pediatr., 2003, 162,449-54.</p><p>Ince E. Cakar N., Tekin M, et al. Arthritis in children with familial Mediterranean fever. Rheumatol. Int., 2002, 21, 213-7.</p><p>Ureten K., Calguneri M., Mesut Onat A. et al. Iterferon alfa in protracted arthritis of familial Mediterranean fever: a robust altrrnative for synovectomy. Ann. Rheum. Dis., 2004, 64, 1527.</p><p>Langevitz P., Livneh A., Zemer D. et al., Seronegative spondloarthropathy in familial Mediterranean fever. Semin. Arthr. Rheum., 1997, 27, 67-72.</p><p>Livneh A., Langevitz P., Zemer D. et al. Criteria for the diagnosis of familial Mediterranean fever. Arthr. Rheum., 1997, 40, 1879-85.</p><p>Kalinich T., Haffer D., Niehues T. et al. Colchicune use in children and adolescents with familial Mediterranean fever: Literature review and consensus statement. Pediatr., 2007, 119, 474-83.</p><p>Frenkel, Kuijk L., Hofhuis W. et al. Anakinra in colchicin resistant Familial Mediterranean Fever in 14th European Paediatric Rheumatology Congress. Sept. 5-9, 2007. Istanbul/Turkey. Abstract book. 252.</p><p>Metyas S., Arkfeld D.G., Forrester D.M., Ehresmann G.R. Infliximab treatment of Familial Mediterranean Fever and its effect to secondary AA amyloidisis. J.Clin. Rheumatol., 2004, 10, 134-7.</p><p>Yuksel S., Yalcinkaya F., Acar B. et al. Clinical improvement with infliximab in a child with amyloidisis secondary to familial Mediterranean fever. Rheumatol., 2006, 45, 1307-8.</p><p>Shinkai K., McCalmont T.H., Leslie K.S. Cryopyrinassotiated periodic syndrome and autoinflammation. Clin. Exp. Dermatol., 2007, 33, 1-9.</p><p>Барабанова О.В., Щербина А.Ю. Аутовоспали- тельные заболевания Практич. рук. по детским болезням под общ. ред. В.Ф.Коколиной и А.Г.Румянцева. Том VIII Иммунология детско- го возрастаю. Под ред. А.Ю. Щербиной и Е.Д.Пашанова. ИД «Медпрактика-М., 2006</p><p>Feldman J. Prieur A.-M., Quartier P. et al. Chronic infantile neurological cutaneouse and artticular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonucleare cells and chondro- cytes. Am.J.Hum. Genet. 2002, 71, 198-203.</p><p>Hoffman H.M. Muller J.L., Broide D.H. et al. Mutation of a new gene encoding a putative pyrine-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat.Genet., 2001, 29, 915-21.</p><p>Neven B., Callebaut I., Prieure A.-M. Molecular basis of the spectral expression of CIAS1 mutations assotiated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS and FCU. Blood, 2004, 103, 2809-15.</p><p>Manji G.A., Wang L., Geddes B.J. et al. PYPAF1, a PYRYN-containing Apaf-like protein that assembles with ASC and regulated activation of NF-kappaB. J.Biol. Chem., 2002, 277, 11570-5.</p><p>Hawkins P.L., Lachmann H.J., Aganna E., McDermott M.F. Spectrum of clinical features in Muckle-Wells Syndrome and response to anakinra. Arthr.Rheum., 2004, 50, 607-12.</p><p>Lovell D.J., Bowyer S.L., Solinger A.M. Interleukine-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset Mutisystem inflammatory disease. Arthr.Rheum., 2005, 52, 1283-6.</p><p>Goldbach-Mansky R., Daily N.J., Canna S.W. et al. Neonatal-Onset Multisystem inflammatory dis- ease responsive to Interleukine-1 inhibition. New Engl.J.Med., 2006, 355, 581-92.</p><p>Kuemmerle-Deschner G.B., Fizaribacliev N. Muckle- Wells syndrome. Effective treatment with Anakinra. Arthr. Rheum., 2007, 56, 9(suppl.), 290.</p><p>Williamson L.M., Hull D., Mehta R. et al. Familial Hibernian fever. Q.J.Med., 1982, 51, 469-480.</p><p>Stjernberg-Salmela S., Ranki A., Karenko et al. The genetic background of Tumor Necrosis Factor-associated periodic syndrome and other systemic auto-inflammatory disorders. Scand. J. Rheumat., 2004, 33, 133-9.</p><p>Kusuhara K., Nomura A., Nakao F., Hara T. Tumor necrosis factor receptor-associated periodic syndrome with a novel mutation in the TNFRSF1A gene in a Japanese family. Eur. J. Pediatr., 2004, 163, 30-2.</p><p>Drewe E., Huggis M.L., Morgan A.G. et al. Treatment of renal amyloidosis with etanercept in tumor necrosis factor receptor-associated periodic syndrome. Rheumatol., 2004, 43, 1405-14.</p><p>Arostegui J.I., Solis P., Aldea A. et al. Etanercept plus colchicines treatment in a child with tumor necrosis factor receptor-associated periodic syndrome abol- ished auto-inflammatory episodes without normilising the subclinical acute phase response. Eur. J. Pediatr. 2005, 164, 13-6.</p><p>van der Meer J.W.H., Vossen J.M., Radl J. et al. Hyperimmunoglobulinemia D and periodic fever:a new syndrome. Lancet, 1984, 1, 1087-90.</p><p>Drenth J.P. Guisset L., Grateau G. et al. Mutation in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. Nat.Genet., 1999, 22, 178-81.</p><p>Bodar E.J., van der Hilst J.C., Drent J.P. et al. Effect of etanercept and anakinra on inflammatory attaks in the hyper-Ig D syndrome: introduction a vaccination provocation model. Neth.J.Med., 2005, 63, 260-4.</p><p>Drenth J.P., Powell R.J., Brown N.S. et al. Interferon-gamma and urine neopterin attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Eur.J.Clin.Invest., 1995, 25, 683-6.</p><p>Takada K., Aksentjevich G., Mahadevan V. et al. Favorable preliminary experience with Etanercept in two patients with hyperimmunoglobulinemia D syndrome and periodic fever syndrome. Arthr. Rheum., 2003, 48, 2645-51.</p><p>Lierl M. Periodic fever syndromes: a diagnostic challenge for the allergist. Allergy, 2007, 62, 1349-58.</p><p>Stojanov S., Hoffman F., Kery A. et al. Cytikine profile in PFAPA syndrome suggest continious inflammation and redused anti-inflammatory response. Eur. Cytokine Netw., 2006, 17, 90-7.</p><p>Jacobs J.C., Goetzl E.J. Streaking leukocyte factor arthritis and pyoderma gangrenosum. Pediatr., 1975, 56, 570-8.</p><p>Lindor N.M., Arsenault T.M., Solomon H.et al. A new autosomal dominant disorders of pyogenic sterile arthritis, pyoderma gangrenosum and acne: PAPA- syndrome. Mayo Clin. Proc., 1997, 72, 611-5</p><p>Wise C.A.,Gillum J.D., Seideman C.E. Mutation in CD2BP discript binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum.Mol.Genet., 2002, 11, 961-9.</p><p>Yeon H.B., Lindor N.M., Seideman J.G. et al. Pyogen arthritis, pyoderma gangrenosum and acne syndrome maps to chromosome 15q. Am.J.Hum.Gen., 2000, 66, 1443-8.</p><p>Cortis E., De Benedetty F., Insalaco A. Abnormal production of tumor necrosis (TNF) alfa and clinical efficacy of the TNF inhibitor etanercept in patient with PAPA syndrome. J.Pediatrics, 2004, 145, 851-5.</p><p>Dierselhuis M.P., Frenkel J., Wulffraat N.M. et al. Anakinra for flares of pyogenic arthritis in PAPA syndrome. Rheumatol., 2005, 44, 406-8.</p><p>Drenth J.P.H., van der Meer W.M. The Inflammasome- A linebacker of innate defense. N.Engl.J.Med., 2006, 355, 730-2.</p><p>Pascual V., Allantaz F., Arce E. et al. Role of interleukin-1 (IL-1) in the patogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J. Exp. Med., 2005, 201, 1479-86. 75</p></div><br />
Рецензия
Для цитирования:
Кузьмина Н.Н., Федоров Е.С., Movsisyan G.R., Салугина С.О. Аутовоспалительные заболевания-современный взгляд на проблему. Научно-практическая ревматология. 2009;47(1):63-75. https://doi.org/10.14412/1995-4484-2009-144
For citation:
Kuzmina N.N., Fedorov E.S., Movsisyan G.R., Salugina S.O. Autoinflammatory diseases – modern view on the problem. Rheumatology Science and Practice. 2009;47(1):63-75. (In Russ.) https://doi.org/10.14412/1995-4484-2009-144
Просмотров:
1051
Послать статью по эл. почте 